Abstract
Down syndrome (DS) is the most common autosomal chromosome anomaly. DS is frequently associated with congenital heart disease (CHD). Patients with DS have 40–60% chance of having CHD. It means that CHD in DS is not only due to trisomy 21 and there are some other genetic factors underlying CHD in DS children. In this study, a total of 240 DNA samples from patients were analyzed including 100 patients with CHD only, 110 patients having CHD along with DS and 30 patients with isolated DS. A cardiovascular gene panel consisting of probes for 406 genes was used to screen DNA samples of all 240 patients for mutation identification. All variants were annotated and common variants were obtained. Briefly, 28 common variants (variants common in two or more than two individuals) were obtained in a group of samples containing DNA from DS patients having CHD as well, 63 variants were found to be unique to DS group of samples and 73 variants have been identified in patients with CHD only. In order to identify genomic variations determining the risk for CHD in DS, only those variants present in DS-CHD group and absent in isolated CHD and/or isolated DS group were considered for further analysis. Variants specific to DS-CHD group were further evaluated based on expression and function data and pathogenicity of the variant of interest. We have implicated mutations in GATA3, KCNH2, ENG, FLNA, and GUSB genes as an underlying risk factor for CHD in DS patients.
Similar content being viewed by others
References
Dooley KJ (2016) Congenital Heart DISEASE and down syndrome. In: Rubin IL, Merrick J, Greydanus DE, Patel DR (eds) Health care for people with intellectual and developmental disabilities across the lifespan. Springer, Cham. https://doi.org/10.1007/978-3-319-18096-0_105
Vis JC, Duffels MG, Winter MM, Weijerman ME, Cobben JM, Huisman SA, Mulder BJ (2009) Down syndrome: a cardiovascular perspective. J Intellect Disabil Res 53(5):419–425
Brodwall K, Greve G, Leirgul E, Klungsøyr K, Holmstrøm H, Vollset SE, Øyen N (2018) The five-year survival of children with down syndrome in Norway 1994–2009 differed by associated congenital heart defects and extracardiac malformations. Acta Paediatr. https://doi.org/10.1111/apa.14223
de Rubens Figueroa J, del Pozzo Magana B, Hach JLP, Jimenez CC, Urbina RC (2003) Heart malformations in children with Down syndrome. Rev Esp Cardiol 56(9):894–899
Jaiyesimi O, Baichoo V (2007) Cardiovascular malformations in Omani Arab children with Down’s syndrome. Cardiol Young 17(2):166–171
Freeman SB, Bean LH, Allen EG, Tinker SW, Locke AE, Druschel C, Hobbs CA, Romitti PA, Royle MH, Torfs CP, Dooley KJ, Sherman SL (2008) Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet Med 10(3):173–180
Plaiasu V (2017) Down syndrome: genetics and cardiogenetics. Maedica (Buchar) 12(3):208–213
Pfitzer C, Helm PC, Rosenthal LM, Berger F, Bauer UMM, Schmitt KR (2018) Dynamics in prevalence of Down syndrome in children with congenital heart disease. Eur J Pediatr 177(1):107–115
Murthy SK, Malhotra AK, Mani S, Shara ME, Al-Rowaished EE, Naveed S, Alkhayat AI, Alali MT (2007) Incidence of Down syndrome in Dubai, UAE. Med Princ Pract 16:25–28
Sailani MR, Makrythanasis P, Valsesia A, Santoni FA, Deutsch S, Popadin K, Borel C, Migliavacca E, Sharp AJ, Duriaux Sail G, Falconnet E, Rabionet K, Serra-Juhé C, Vicari S, Laux D, Grattau Y, Dembour G, Megarbane A, Touraine R, Stora S, Kitsiou S, Fryssira H, Chatzisevastou-Loukidou C, Kanavakis E, Merla G, Bonnet D, Pérez-Jurado LA, Estivill X, Delabar JM, Antonarakis SE (2013) The complex SNP and CNV genetic architecture of the increased risk of congenital heart defects in Down syndrome. Genome Res 23(9):1410–1421
Bruneau BG (2008) The developmental genetics of congenital heart disease. Nature 451:943–948
Ackerman C, Locke AE, Feingold E, Reshey B, Espana K, Thusberg J, Mooney S, Bean LJ, Dooley KJ, Cua CL, Reeves RH, Sherman SL, Maslen CL (2012) An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects. Am J Hum Genet 91:646–659
Funding
This study was funded by King Abdul Aziz City for Science and Technology (Grant No. AT-34-369).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Taibah University ethical research committee, ethical review board of Madinah Maternity and Children Hospital and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consents were obtained from all individual participants included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Alharbi, K.M., Al-Mazroea, A.H., Abdallah, A.M. et al. Targeted Next-Generation Sequencing of 406 Genes Identified Genetic Defects Underlying Congenital Heart Disease in Down Syndrome Patients. Pediatr Cardiol 39, 1676–1680 (2018). https://doi.org/10.1007/s00246-018-1951-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-018-1951-3